Exposure-Response Relationships for the Efficacy and Safety of Risankizumab in Japanese Subjects with Psoriasis.
Ahmed A SuleimanAmit KhatriRajneet K OberoiAhmed A OthmanPublished in: Clinical pharmacokinetics (2021)
NCT03000075, NCT03022045, NCT02672852, NCT02684357, NCT02684370, NCT02694523, NCT02054481.
Keyphrases